$FLGT
Fulgent Genetics, Inc. Stock $flgt

$flgt Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000095017024123684 Filed on November 08, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$71.74M	$84.69M
YoY Change		-15.28%	-19.85%
Cost Of Revenue		$44.97M	$44.84M
YoY Change		0.29%	-24.71%
Gross Profit		$26.77M	$39.84M
YoY Change		-32.81%	-13.56%
Gross Profit Margin		37.32%	47.05%
Selling, General & Admin		$30.07M	$27.66M
YoY Change		8.73%	-23.44%
% of Gross Profit		112.34%	69.42%
Research & Development		$11.78M	$10.01M
YoY Change		17.67%	33.4%
% of Gross Profit		44.01%	25.13%
Depreciation & Amortization		$5.920M	$4.300M
YoY Change		37.67%	-43.42%
% of Gross Profit		22.11%	10.79%
Operating Expenses		$43.85M	$39.63M
YoY Change		10.65%	-13.36%
Operating Profit		-$17.08M	$214.0K
YoY Change		-8080.84%	-39.2%
Interest Expense		$8.076M	$0.00
YoY Change			-100.0%
% of Operating Profit			0.0%
Other Income/Expense, Net		-$1.453M	$6.646M
YoY Change		-121.86%
Pretax Income		-$18.53M	$6.860M
YoY Change		-370.15%	290.44%
Income Tax		-$3.800M	$20.30M
% Of Pretax Income			295.92%
Net Earnings		-$14.65M	-$13.11M
YoY Change		11.76%	-862.48%
Net Earnings / Revenue		-20.42%	-15.48%
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.48	-$0.44
COMMON SHARES
Basic Shares Outstanding	30.59M	30.30M	29.93M
Diluted Shares Outstanding		30.42M	30.01M

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$213.1M	$467.8M
YoY Change	-54.45%	-18.08%
Cash & Equivalents	$58.04M	$84.08M
Short-Term Investments	$155.0M	$383.7M
Other Short-Term Assets	$56.16M	$32.78M
YoY Change	71.33%	53.19%
Inventory
Prepaid Expenses	$7.070M	$7.583M
Receivables	$57.32M	$49.28M
Other Receivables	$1.270M	$1.115M
Total Short-Term Assets	$326.5M	$549.9M
YoY Change	-40.61%	-21.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$106.8M	$85.27M
YoY Change	25.27%	4.23%
Goodwill	$22.06M	$141.8M
YoY Change	-84.45%	17.9%
Intangibles	$137.1M	$144.5M
YoY Change	-5.1%	64.47%
Long-Term Investments	$602.2M	$383.7M
YoY Change	56.95%	10.59%
Other Assets	$39.01M	$38.13M
YoY Change	2.32%	-37.51%
Total Long-Term Assets	$907.2M	$808.5M
YoY Change	12.2%	14.01%
TOTAL ASSETS
Total Short-Term Assets	$326.5M	$549.9M
Total Long-Term Assets	$907.2M	$808.5M
Total Assets	$1.234B	$1.358B
YoY Change	-9.18%	-3.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.81M	$15.77M
YoY Change	25.57%	8.92%
Accrued Expenses	$23.86M	$21.03M
YoY Change	13.46%	-16.21%
Deferred Revenue	$2.966M	$2.586M
YoY Change	14.69%	-0.65%
Short-Term Debt	$0.00	$2.900M
YoY Change	-100.0%	-85.84%
Long-Term Debt Due	$412.0K	$500.0K
YoY Change	-17.6%	-46.06%
Total Short-Term Liabilities	$73.99M	$61.42M
YoY Change	20.46%	-40.09%
LONG-TERM LIABILITIES
Long-Term Debt	$448.0K	$900.0K
YoY Change	-50.22%	-56.1%
Other Long-Term Liabilities	$11.82M	$15.76M
YoY Change	-25.01%	-21.37%
Total Long-Term Liabilities	$11.82M	$15.76M
YoY Change	-25.01%	-21.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$73.99M	$61.42M
Total Long-Term Liabilities	$11.82M	$15.76M
Total Liabilities	$98.87M	$96.56M
YoY Change	2.38%	-22.37%
SHAREHOLDERS EQUITY
Retained Earnings	$596.4M	$761.3M
YoY Change	-21.67%	-7.7%
Common Stock	$532.9M	$514.3M
YoY Change	3.63%	7.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.138B	$1.259B
YoY Change
Total Liabilities & Shareholders Equity	$1.234B	$1.358B
YoY Change	-9.18%	-3.37%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$14.65M	-$13.11M
YoY Change	11.76%	-862.48%
Depreciation, Depletion And Amortization	$5.920M	$4.300M
YoY Change	37.67%	-43.42%
Cash From Operating Activities	-$15.51M	$10.30M
YoY Change	-250.57%	-50.42%
INVESTING ACTIVITIES
Capital Expenditures	$19.54M	$4.900M
YoY Change	298.71%	-190.16%
Acquisitions
YoY Change
Other Investing Activities	$28.52M	$25.00M
YoY Change	14.09%	-49.72%
Cash From Investing Activities	$8.985M	$20.10M
YoY Change	-55.3%	-54.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-567.0K	-4.400M
YoY Change	-87.11%	-87.59%
NET CHANGE
Cash From Operating Activities	-15.51M	10.30M
Cash From Investing Activities	8.985M	20.10M
Cash From Financing Activities	-567.0K	-4.400M
Net Change In Cash	-7.091M	26.00M
YoY Change	-127.27%	-12.17%
FREE CASH FLOW
Cash From Operating Activities	-$15.51M	$10.30M
Capital Expenditures	$19.54M	$4.900M
Free Cash Flow	-$35.05M	$5.400M
YoY Change	-749.0%	-79.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001674930
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
	dei	Entity Central Index Key EntityCentralIndexKey	0001674930
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q3	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q3	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Registrant Name EntityRegistrantName	FULGENT GENETICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37894
	dei	Entity Registrant Name EntityRegistrantName	FULGENT GENETICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-2621304
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4399 Santa Anita Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	El Monte
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91731
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-2621304
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4399 Santa Anita Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	El Monte
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91731
	dei	City Area Code CityAreaCode	626
	dei	City Area Code CityAreaCode	626
	dei	Local Phone Number LocalPhoneNumber	350-0537
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	FLGT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Local Phone Number LocalPhoneNumber	350-0537
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	FLGT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30586811
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58042000
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30586811
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58042000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97473000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97473000
CY2024Q3	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Current AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesCurrent	155027000
CY2024Q3	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Current AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesCurrent	155027000
CY2023Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Current AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesCurrent	326681000
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25316000
CY2023Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Current AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesCurrent	326681000
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25316000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25226000
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	57315000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51132000
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	56155000
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	57315000
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	56155000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	32559000
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	602232000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	32559000
CY2024Q3	us-gaap	Assets Current AssetsCurrent	326539000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	507845000
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	602232000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	423571000
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	137115000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	143053000
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106810000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83464000
CY2024Q3	us-gaap	Goodwill Goodwill	22055000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	423571000
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	137115000
CY2024Q3	us-gaap	Goodwill Goodwill	22055000
CY2023Q4	us-gaap	Goodwill Goodwill	22055000
CY2023Q4	flgt	Redeemable Preferred Stock Investment Noncurrent RedeemablePreferredStockInvestmentNoncurrent	20438000
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	39012000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34902000
CY2023Q4	us-gaap	Goodwill Goodwill	22055000
CY2023Q4	flgt	Redeemable Preferred Stock Investment Noncurrent RedeemablePreferredStockInvestmentNoncurrent	20438000
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	39012000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	34902000
CY2024Q3	us-gaap	Assets Assets	1233763000
CY2023Q4	us-gaap	Assets Assets	1235328000
CY2024Q3	us-gaap	Assets Assets	1233763000
CY2023Q4	us-gaap	Assets Assets	1235328000
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	19805000
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	19805000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	15360000
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23862000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30737000
CY2024Q3	flgt	Customer Deposit CustomerDeposit	26945000
CY2023Q4	flgt	Customer Deposit CustomerDeposit	22700000
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2966000
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23862000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30737000
CY2024Q3	flgt	Customer Deposit CustomerDeposit	26945000
CY2023Q4	flgt	Customer Deposit CustomerDeposit	22700000
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2966000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2874000
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	412000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73018000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7962000
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6326000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5978000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2874000
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	412000
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1183000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	164000
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	73990000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73018000
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6734000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7962000
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6326000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5978000
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11815000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15084000
CY2024Q3	us-gaap	Liabilities Liabilities	98865000
CY2023Q4	us-gaap	Liabilities Liabilities	102042000
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11815000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33310000
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30537000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32416000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29653000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29653000
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	3000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3000
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	633175000
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	1138445000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1133286000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	207256000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	218708000
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	532909000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	501718000
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	9178000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1205000
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	596355000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	633175000
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	1138445000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1136101000
CY2024Q3	us-gaap	Minority Interest MinorityInterest	-3547000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-2815000
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1134898000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1133286000
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1233763000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1235328000
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71743000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84687000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	207256000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	218708000
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	44972000
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	44843000
	us-gaap	Cost Of Revenue CostOfRevenue	131890000
	us-gaap	Cost Of Revenue CostOfRevenue	139481000
CY2024Q3	us-gaap	Gross Profit GrossProfit	26771000
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	44972000
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	44843000
	us-gaap	Cost Of Revenue CostOfRevenue	131890000
	us-gaap	Cost Of Revenue CostOfRevenue	139481000
CY2024Q3	us-gaap	Gross Profit GrossProfit	26771000
CY2023Q3	us-gaap	Gross Profit GrossProfit	39844000
	us-gaap	Gross Profit GrossProfit	75366000
	us-gaap	Gross Profit GrossProfit	79227000
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11783000
CY2023Q3	us-gaap	Gross Profit GrossProfit	39844000
	us-gaap	Gross Profit GrossProfit	79227000
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11783000
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10014000
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10014000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36703000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29488000
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9124000
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10161000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26708000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	30967000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36703000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29488000
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9124000
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10161000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26708000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	30967000
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20950000
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20950000
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17498000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	63765000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	57293000
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17498000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	63765000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5973000
	us-gaap	Operating Expenses OperatingExpenses	133149000
	us-gaap	Operating Expenses OperatingExpenses	123635000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-44408000
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	8090000
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	6472000
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1993000
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1957000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5973000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5887000
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	43850000
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	39630000
	us-gaap	Operating Expenses OperatingExpenses	133149000
	us-gaap	Operating Expenses OperatingExpenses	123635000
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-17079000
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	214000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-57783000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-44408000
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	8090000
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	6472000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	23181000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	15802000
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	14000
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	70000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	23181000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	15802000
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	14000
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	70000
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	-210000
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	625000
	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10073000
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	544000
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	244000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	554000
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	-210000
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	625000
CY2024Q3	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10073000
	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10073000
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	544000
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	244000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	554000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	342000
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1453000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	342000
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1453000
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6646000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13872000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15519000
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6646000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13872000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15519000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18532000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6860000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43911000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28889000
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3838000
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20326000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43911000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28889000
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3838000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12016000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6281000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12016000
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-14694000
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-14694000
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-13466000
	us-gaap	Profit Loss ProfitLoss	-37630000
	us-gaap	Profit Loss ProfitLoss	-40905000
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-46000
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-359000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-810000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1229000
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-14648000
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-13107000
	us-gaap	Net Income Loss NetIncomeLoss	-36820000
	us-gaap	Net Income Loss NetIncomeLoss	-39676000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.48
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.44
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.22
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.33
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.48
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.44
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.22
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.33
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30416000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30013000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30095000
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-13466000
	us-gaap	Profit Loss ProfitLoss	-37630000
	us-gaap	Profit Loss ProfitLoss	-40905000
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-46000
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-359000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-810000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1229000
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-14648000
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-13107000
	us-gaap	Net Income Loss NetIncomeLoss	-36820000
	us-gaap	Net Income Loss NetIncomeLoss	-39676000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.48
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.44
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.22
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.33
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.48
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.44
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.22
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.33
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30416000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30013000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30095000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29789000
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30416000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30013000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30095000
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-13466000
	us-gaap	Profit Loss ProfitLoss	-37630000
	us-gaap	Profit Loss ProfitLoss	-40905000
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	718000
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-230000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	274000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-2027000
CY2024Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	9537000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29789000
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30416000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30013000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30095000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29789000
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-14694000
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-13466000
	us-gaap	Profit Loss ProfitLoss	-37630000
	us-gaap	Profit Loss ProfitLoss	-40905000
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	718000
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-230000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	274000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-2027000
CY2024Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	9537000
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4017000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7777000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7214000
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-4439000
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9679000
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-29579000
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-35718000
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-46000
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-359000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-810000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1229000
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	200000
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-68000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	78000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	1175000
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	154000
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-427000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-732000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-54000
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4593000
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9252000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28847000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-35664000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1133286000
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11518000
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1682000
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	225000
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2405000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-13846000
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	201000
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-9090000
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1128848000
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10920000
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	4017000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7777000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7214000
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-4439000
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9679000
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-29579000
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-35718000
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-46000
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-359000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-810000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1229000
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	200000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	78000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	1175000
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	154000
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-427000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-732000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-54000
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4593000
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9252000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-35664000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1133286000
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2405000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-13846000
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1126646000
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11635000
CY2024Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	544000
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	201000
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-9090000
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1128848000
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10920000
CY2024Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	431000
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	10255000
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-14694000
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1134898000
CY2024Q3	flgt	Common Stock Shares Issued Upon Expiration Of Hold Back Provisions CommonStockSharesIssuedUponExpirationOfHoldBackProvisions	185503000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1269875000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10265000
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	869000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5497000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-15849000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1268919000
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10323000
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	232000
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4097000
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting periods. These estimates, judgments and assumptions are based on historical data and experience available at the date of the accompanying condensed consolidated financial statements, as well as various other factors management believes to be reasonable under the circumstances. The Company’s estimates and assumptions may evolve as conditions change. Actual results could differ significantly from these estimates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On an on-going basis, management evaluates its estimates, primarily those related to: (i) revenue recognition criteria, (ii) accounts receivable and allowances for credit losses, (iii) the useful lives of fixed assets and intangible assets, (iv) estimates of tax liabilities, (v) valuation of intangible assets and goodwill at time of acquisition and on a recurring basis, and (vi) valuation of investments.</span></p>
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	100000
CY2024Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	431000
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	10255000
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1134898000
CY2024Q3	flgt	Common Stock Shares Issued Upon Expiration Of Hold Back Provisions CommonStockSharesIssuedUponExpirationOfHoldBackProvisions	185503000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1269875000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10265000
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	869000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5497000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-15849000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1268919000
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10323000
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	232000
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4097000
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-11590000
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1263326000
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10902000
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	517000
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2198000
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3787000
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-13466000
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1261834000
CY2023Q3	flgt	Common Stock Shares Not Issued And Holdback As Partial Security For Indemnification Obligations CommonStockSharesNotIssuedAndHoldbackAsPartialSecurityForIndemnificationObligations	371006000
CY2023Q4	flgt	Common Stock Shares Issued Upon Expiration Of Hold Back Provisions CommonStockSharesIssuedUponExpirationOfHoldBackProvisions	185503000
CY2024Q2	flgt	Common Stock Shares Issued Upon Expiration Of Hold Back Provisions CommonStockSharesIssuedUponExpirationOfHoldBackProvisions	185503000
	us-gaap	Profit Loss ProfitLoss	-37630000
	us-gaap	Profit Loss ProfitLoss	-40905000
	us-gaap	Share Based Compensation ShareBasedCompensation	34073000
	us-gaap	Share Based Compensation ShareBasedCompensation	31490000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18736000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19610000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-3210000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-4331000
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3283000
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4895000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-217000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-429000
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	4005000
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	2382000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3372000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	10964000
	flgt	Unrecognized Tax Benefits Operating Activities UnrecognizedTaxBenefitsOperatingActivities	-348000
	flgt	Unrecognized Tax Benefits Operating Activities UnrecognizedTaxBenefitsOperatingActivities	281000
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-942000
	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10073000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-14000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	29000
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-11590000
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1263326000
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10902000
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	517000
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2198000
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3787000
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-13466000
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1261834000
CY2023Q3	flgt	Common Stock Shares Not Issued And Holdback As Partial Security For Indemnification Obligations CommonStockSharesNotIssuedAndHoldbackAsPartialSecurityForIndemnificationObligations	371006000
CY2023Q4	flgt	Common Stock Shares Issued Upon Expiration Of Hold Back Provisions CommonStockSharesIssuedUponExpirationOfHoldBackProvisions	185503000
CY2024Q2	flgt	Common Stock Shares Issued Upon Expiration Of Hold Back Provisions CommonStockSharesIssuedUponExpirationOfHoldBackProvisions	185503000
	us-gaap	Profit Loss ProfitLoss	-37630000
	us-gaap	Profit Loss ProfitLoss	-40905000
	us-gaap	Share Based Compensation ShareBasedCompensation	34073000
	us-gaap	Share Based Compensation ShareBasedCompensation	31490000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18736000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19610000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-3210000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-4331000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-217000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-429000
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	4005000
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	2382000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3372000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	10964000
	flgt	Unrecognized Tax Benefits Operating Activities UnrecognizedTaxBenefitsOperatingActivities	281000
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	-942000
	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10073000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-14000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	29000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2978000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7596000
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	20199000
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	469000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	576000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2407000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3874000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7025000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	93000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-613000
	flgt	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	4236000
	flgt	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	7986000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-4589000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-7696000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3288000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4762000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3958000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2978000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7596000
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	20199000
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	469000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	576000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2407000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3874000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7025000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	93000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-613000
	flgt	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	4236000
	flgt	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	7986000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-4589000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-7696000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3288000
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4762000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3958000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12070000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	374209000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	343601000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	36537000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19101000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	278008000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	376890000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	313000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30897000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2657000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1618000
	flgt	Repayment Of Notes Payable RepaymentOfNotesPayable	1230000
	flgt	Repayment Of Notes Payable RepaymentOfNotesPayable	2429000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	408000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	592000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	225000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2198000
	flgt	Repayment Of Investment Margin Loan RepaymentOfInvestmentMarginLoan	15000000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4520000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21834000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-39296000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4570000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97473000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79506000
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58177000
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84076000
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58042000
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84076000
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	135000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12070000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	374209000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	343601000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	36537000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19101000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	278008000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	376890000
	flgt	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	101528000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	313000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	440000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30897000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14628000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2657000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1618000
	flgt	Repayment Of Notes Payable RepaymentOfNotesPayable	1230000
	flgt	Repayment Of Notes Payable RepaymentOfNotesPayable	2429000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	408000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	592000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	225000
	flgt	Repayment Of Investment Margin Loan RepaymentOfInvestmentMarginLoan	15000000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4520000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21834000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-294000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-39296000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4570000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97473000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79506000
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58177000
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84076000
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58042000
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84076000
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	135000
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58177000
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84076000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	26642000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2698000
	us-gaap	Interest Paid Net InterestPaidNet	462000
	us-gaap	Interest Paid Net InterestPaidNet	940000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	2488000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1288000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1158000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2661000
	flgt	Operating Lease Right Of Use Assets Reduced Due To Lease Modification And Termination OperatingLeaseRightOfUseAssetsReducedDueToLeaseModificationAndTermination	57000
	flgt	Operating Lease Liabilities Removed Due To Purchasing Underlying Assets OperatingLeaseLiabilitiesRemovedDueToPurchasingUnderlyingAssets	2799000
	flgt	Finance Lease Right Of Use Assets Reduced Due To Lease Modification And Termination FinanceLeaseRightOfUseAssetsReducedDueToLeaseModificationAndTermination	696000
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	0
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25226000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-3210000
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4310000
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	7610000
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58177000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2698000
	us-gaap	Interest Paid Net InterestPaidNet	462000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	2488000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	1288000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1158000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2661000
	flgt	Operating Lease Right Of Use Assets Reduced Due To Lease Modification And Termination OperatingLeaseRightOfUseAssetsReducedDueToLeaseModificationAndTermination	57000
	flgt	Operating Lease Liabilities Removed Due To Purchasing Underlying Assets OperatingLeaseLiabilitiesRemovedDueToPurchasingUnderlyingAssets	2799000
	flgt	Finance Lease Right Of Use Assets Reduced Due To Lease Modification And Termination FinanceLeaseRightOfUseAssetsReducedDueToLeaseModificationAndTermination	696000
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting periods. These estimates, judgments and assumptions are based on historical data and experience available at the date of the accompanying condensed consolidated financial statements, as well as various other factors management believes to be reasonable under the circumstances. The Company’s estimates and assumptions may evolve as conditions change. Actual results could differ significantly from these estimates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On an on-going basis, management evaluates its estimates, primarily those related to: (i) revenue recognition criteria, (ii) accounts receivable and allowances for credit losses, (iii) the useful lives of fixed assets and intangible assets, (iv) estimates of tax liabilities, (v) valuation of intangible assets and goodwill at time of acquisition and on a recurring basis, and (vi) valuation of investments.</span></p>
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	100000
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	0
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25226000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-3210000
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4310000
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	7610000
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25316000
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	25316000
CY2023Q4	flgt	Redeemable Preferred Stock Investment Noncurrent RedeemablePreferredStockInvestmentNoncurrent	20400000
CY2023Q4	flgt	Redeemable Preferred Stock Investment Shares Held RedeemablePreferredStockInvestmentSharesHeld	7300000
CY2024Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7300000
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	400000
CY2024Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2024Q3	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10100000
	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10100000
CY2023Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0
	us-gaap	Debt Securities Held To Maturity Transfer To Available For Sale Allowance For Credit Loss Expense DebtSecuritiesHeldToMaturityTransferToAvailableForSaleAllowanceForCreditLossExpense	10073000
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	10073000
CY2024Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0
CY2023Q4	flgt	Redeemable Preferred Stock Investment Noncurrent RedeemablePreferredStockInvestmentNoncurrent	20400000
CY2023Q4	flgt	Redeemable Preferred Stock Investment Shares Held RedeemablePreferredStockInvestmentSharesHeld	7300000
CY2024Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7300000
CY2024Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	400000
CY2024Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2024Q3	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10100000
	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10100000
CY2023Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0
	us-gaap	Debt Securities Held To Maturity Transfer To Available For Sale Allowance For Credit Loss Expense DebtSecuritiesHeldToMaturityTransferToAvailableForSaleAllowanceForCreditLossExpense	10073000
	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff	10073000
CY2024Q3	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk, Customers, and Suppliers</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, trade accounts receivable, and marketable securities. As of September 30, 2024, substantially all of the Company’s cash and cash equivalents were deposited in accounts at financial institutions, and amounts may exceed federally insured limits. Management believes that the Company is not exposed to significant credit risk due to the financial strength of the depository institutions in which its cash and cash equivalents are held.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In certain periods, a small number of customers has accounted for a significant portion of the Company’s revenue. For the laboratory services business, aggregating customers under common control, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customer comprised of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">16.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">23</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, of total revenue in the three months ended September 30, 2024 and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">45.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">22</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, of the Company's revenue in the nine months ended September 30, 2024. The same customer contributed </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, of the Company's revenue in the three months ended September 30, 2023 and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">24.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, of the Company's revenue in the nine months ended September 30, 2023. The same customer comprised </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of total accounts receivable, net, as of September 30, 2024, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of total accounts receivable, net, as of December 31, 2023. For the therapeutic development business, as of September 30, 2024 and December 31, 2023, there is no concentration risk in customers, as it does not have any commercialized or approved product candidates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company relies on a limited number of suppliers for certain laborat</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ory substances used in the chemical reactions incorporated into its processes, referred to as reagents, as well as for the sequencers and various other equipment and materials it uses in its laboratory operations. In particular, the Company relies on a sole supplier for the next generation sequencers and associated reagents it uses to perform its genetic tests and as the sole provider of maintenance and repair services for these sequencers. The operations of the laboratory services business would be interrupted if it encountered delays or difficulties securing these reagents, sequencers, other equipment or materials or maintenance and repair services, which could occur for a variety of reasons, including if the Company needs a replacement or temporary substitute for any of its limited or sole suppliers and is not able to locate and make arrangements with an acceptable replacement or temporary substitute. The Company's development efforts could also be delayed or interrupted if it is unable to procure items needed for its therapeutic development activities. The Company’s therapeutic development business also relies on ANP Technologies, Inc., or ANP, for certain laboratory services, equipment, tools, and drug intermediates in connection with research and development efforts. The Company believes there are currently only a few other manufacturers that are capable of supplying and servicing some of the equipment and other materials necessary for its laboratory operations, including collection kits, sequencers and various associated reagents.</span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk, Customers, and Suppliers</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, trade accounts receivable, and marketable securities. As of September 30, 2024, substantially all of the Company’s cash and cash equivalents were deposited in accounts at financial institutions, and amounts may exceed federally insured limits. Management believes that the Company is not exposed to significant credit risk due to the financial strength of the depository institutions in which its cash and cash equivalents are held.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In certain periods, a small number of customers has accounted for a significant portion of the Company’s revenue. For the laboratory services business, aggregating customers under common control, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customer comprised of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">16.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">23</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, of total revenue in the three months ended September 30, 2024 and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">45.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">22</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, of the Company's revenue in the nine months ended September 30, 2024. The same customer contributed </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">12.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, of the Company's revenue in the three months ended September 30, 2023 and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">24.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, of the Company's revenue in the nine months ended September 30, 2023. The same customer comprised </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of total accounts receivable, net, as of September 30, 2024, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">13</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of total accounts receivable, net, as of December 31, 2023. For the therapeutic development business, as of September 30, 2024 and December 31, 2023, there is no concentration risk in customers, as it does not have any commercialized or approved product candidates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company relies on a limited number of suppliers for certain laborat</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ory substances used in the chemical reactions incorporated into its processes, referred to as reagents, as well as for the sequencers and various other equipment and materials it uses in its laboratory operations. In particular, the Company relies on a sole supplier for the next generation sequencers and associated reagents it uses to perform its genetic tests and as the sole provider of maintenance and repair services for these sequencers. The operations of the laboratory services business would be interrupted if it encountered delays or difficulties securing these reagents, sequencers, other equipment or materials or maintenance and repair services, which could occur for a variety of reasons, including if the Company needs a replacement or temporary substitute for any of its limited or sole suppliers and is not able to locate and make arrangements with an acceptable replacement or temporary substitute. The Company's development efforts could also be delayed or interrupted if it is unable to procure items needed for its therapeutic development activities. The Company’s therapeutic development business also relies on ANP Technologies, Inc., or ANP, for certain laboratory services, equipment, tools, and drug intermediates in connection with research and development efforts. The Company believes there are currently only a few other manufacturers that are capable of supplying and servicing some of the equipment and other materials necessary for its laboratory operations, including collection kits, sequencers and various associated reagents.</span></p>
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
	flgt	Tax Effect Of Adjustments Recognized As Benefit TaxEffectOfAdjustmentsRecognizedAsBenefit	2100000
CY2024Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	2700000
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	3500000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
	flgt	Tax Effect Of Adjustments Recognized As Benefit TaxEffectOfAdjustmentsRecognizedAsBenefit	2100000
CY2024Q3	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	2700000
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	3500000
CY2024Q3	flgt	Tax Effects Related To Unrealized Holding Loss On Available For Sale Debt Securities TaxEffectsRelatedToUnrealizedHoldingLossOnAvailableForSaleDebtSecurities	0
	flgt	Tax Effects Related To Unrealized Holding Loss On Available For Sale Debt Securities TaxEffectsRelatedToUnrealizedHoldingLossOnAvailableForSaleDebtSecurities	0
CY2023Q3	flgt	Tax Effects Related To Unrealized Holding Loss On Available For Sale Debt Securities TaxEffectsRelatedToUnrealizedHoldingLossOnAvailableForSaleDebtSecurities	1200000
	flgt	Tax Effects Related To Unrealized Holding Loss On Available For Sale Debt Securities TaxEffectsRelatedToUnrealizedHoldingLossOnAvailableForSaleDebtSecurities	2400000
CY2024Q3	flgt	Variable Consideration VariableConsideration	0
CY2024Q3	flgt	Tax Effects Related To Unrealized Holding Loss On Available For Sale Debt Securities TaxEffectsRelatedToUnrealizedHoldingLossOnAvailableForSaleDebtSecurities	0
	flgt	Tax Effects Related To Unrealized Holding Loss On Available For Sale Debt Securities TaxEffectsRelatedToUnrealizedHoldingLossOnAvailableForSaleDebtSecurities	0
CY2023Q3	flgt	Tax Effects Related To Unrealized Holding Loss On Available For Sale Debt Securities TaxEffectsRelatedToUnrealizedHoldingLossOnAvailableForSaleDebtSecurities	1200000
	flgt	Tax Effects Related To Unrealized Holding Loss On Available For Sale Debt Securities TaxEffectsRelatedToUnrealizedHoldingLossOnAvailableForSaleDebtSecurities	2400000
CY2024Q3	flgt	Variable Consideration VariableConsideration	0
	flgt	Variable Consideration VariableConsideration	1800000
	flgt	Variable Consideration VariableConsideration	18900000
CY2023Q3	flgt	Variable Consideration VariableConsideration	18900000
CY2024Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0
CY2024Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	800000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1600000
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	700000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2200000
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Prior Period Reclassifications</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain amounts reported in the prior period have been reclassified to conform with the current period presentation. The Company has separated prepaid income taxes from other current and long-term assets and separated customer deposits and contract liabilities from accrued liabilities and other liabilities in the Condensed Consolidated Statements of Cash Flow. The Company has also separated interest income and interest expenses from other income (expense) in the Condensed Consolidated Statements of Operations.</span></p>
CY2024Q3	flgt	Cash Equivalents CashEquivalents	41104000
CY2024Q3	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Gain Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedGainBeforeTax	6618000
CY2024Q3	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Loss Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedLossBeforeTax	732000
CY2024Q3	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecurities	782186000
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	38291000
CY2023Q4	flgt	Cash Equivalents CashEquivalents	38291000
CY2023Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Amortized Cost Basis AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesAmortizedCostBasis	789726000
CY2023Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Gain Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedGainBeforeTax	1909000
CY2023Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Loss Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedLossBeforeTax	5945000
CY2023Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecurities	785690000
	flgt	Available For Sale Debt Securities And Equity Trading Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesAndEquityTradingSecuritiesGrossUnrealizedLoss	700000
CY2023	flgt	Available For Sale Debt Securities And Equity Trading Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesAndEquityTradingSecuritiesGrossUnrealizedLoss	5900000
CY2024Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	25900000
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	101500000
	flgt	Variable Consideration VariableConsideration	1800000
	flgt	Variable Consideration VariableConsideration	18900000
CY2023Q3	flgt	Variable Consideration VariableConsideration	18900000
CY2024Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0
CY2024Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	800000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1600000
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	700000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2200000
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	41104000
CY2024Q3	flgt	Cash Equivalents CashEquivalents	41104000
CY2024Q3	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Amortized Cost Basis AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesAmortizedCostBasis	776300000
CY2024Q3	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Gain Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedGainBeforeTax	6618000
CY2024Q3	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Loss Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedLossBeforeTax	732000
CY2024Q3	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecurities	782186000
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	38291000
CY2023Q4	flgt	Cash Equivalents CashEquivalents	38291000
CY2023Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Amortized Cost Basis AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesAmortizedCostBasis	789726000
CY2023Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Gain Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedGainBeforeTax	1909000
CY2023Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities Unrealized Loss Before Tax AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecuritiesUnrealizedLossBeforeTax	5945000
CY2023Q4	flgt	Available For Sale Securities Debt Equity Securities And Trading Securities AvailableForSaleSecuritiesDebtEquitySecuritiesAndTradingSecurities	785690000
	flgt	Available For Sale Debt Securities And Equity Trading Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesAndEquityTradingSecuritiesGrossUnrealizedLoss	700000
CY2023	flgt	Available For Sale Debt Securities And Equity Trading Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesAndEquityTradingSecuritiesGrossUnrealizedLoss	5900000
CY2024Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	25900000
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	101500000
CY2024Q3	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	100000
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	1000000
CY2023Q3	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0
CY2023Q3	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0
CY2024Q3	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10100000
	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10100000
CY2024Q3	flgt	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
CY2023Q3	flgt	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
	flgt	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
	flgt	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	155923000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	135097000
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	49113000
CY2024Q3	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	100000
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	1000000
CY2023Q3	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0
CY2023Q3	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0
CY2024Q3	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10100000
	flgt	Impairment Of Available For Sale Debt Securities ImpairmentOfAvailableForSaleDebtSecurities	10100000
CY2024Q3	flgt	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
CY2023Q3	flgt	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	155923000
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106810000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83464000
CY2024Q3	us-gaap	Depreciation Depreciation	3800000
	us-gaap	Depreciation Depreciation	12400000
CY2023Q3	us-gaap	Depreciation Depreciation	4300000
	us-gaap	Depreciation Depreciation	13100000
CY2024Q3	us-gaap	Prepaid Taxes PrepaidTaxes	32873000
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	12675000
CY2024Q3	flgt	Reagents And Supplies Current ReagentsAndSuppliesCurrent	8632000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7744000
CY2024Q3	flgt	Marketable Securities Interest Receivable Current MarketableSecuritiesInterestReceivableCurrent	6310000
CY2023Q4	flgt	Marketable Securities Interest Receivable Current MarketableSecuritiesInterestReceivableCurrent	4994000
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1270000
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1319000
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	56155000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	32559000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	51633000
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106810000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83464000
CY2024Q3	us-gaap	Depreciation Depreciation	3800000
	us-gaap	Depreciation Depreciation	12400000
CY2023Q3	us-gaap	Depreciation Depreciation	4300000
	us-gaap	Depreciation Depreciation	13100000
CY2024Q3	us-gaap	Prepaid Taxes PrepaidTaxes	32873000
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	12675000
CY2024Q3	flgt	Reagents And Supplies Current ReagentsAndSuppliesCurrent	8632000
CY2023Q4	flgt	Reagents And Supplies Current ReagentsAndSuppliesCurrent	5827000
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7070000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7744000
CY2024Q3	flgt	Marketable Securities Interest Receivable Current MarketableSecuritiesInterestReceivableCurrent	6310000
CY2023Q4	flgt	Marketable Securities Interest Receivable Current MarketableSecuritiesInterestReceivableCurrent	4994000
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1270000
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1319000
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	56155000
CY2024Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	5466000
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	5741000
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	4613000
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	6255000
CY2024Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	4171000
CY2023Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	3543000
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4069000
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7026000
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1481000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3957000
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4062000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4215000
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23862000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30737000
CY2024Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	5466000
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	5741000
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	4613000
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	6255000
CY2024Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	4171000
CY2023Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	3543000
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4069000
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7026000
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1481000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3957000
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4062000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4215000
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23862000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30737000
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4662000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7147000
CY2024Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	2493000
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2964000
CY2024Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	4660000
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	4973000
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11815000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15084000
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71743000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84687000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	207256000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	218708000
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4662000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7147000
CY2024Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	2493000
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2964000
CY2024Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	4660000
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	4973000
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11815000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15084000
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71743000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84687000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	207256000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	218708000
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-17079000
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	214000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-57783000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-44408000
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1453000
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6646000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13872000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15519000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18532000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6860000
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5920000
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6419000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18736000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19610000
CY2024Q3	us-gaap	Assets Assets	1233763000
CY2023Q4	us-gaap	Assets Assets	1235328000
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-17079000
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	214000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-57783000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-44408000
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1453000
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6646000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13872000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15519000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18532000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6860000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43911000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28889000
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5920000
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6419000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18736000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19610000
CY2024Q3	us-gaap	Assets Assets	1233763000
CY2023Q4	us-gaap	Assets Assets	1235328000
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71743000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84687000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	207256000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	218708000
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	106810000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83464000
CY2024Q3	us-gaap	Purchase Obligation PurchaseObligation	42100000
CY2024Q3	us-gaap	Recorded Unconditional Purchase Obligation Due In Next Rolling Twelve Months RecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths	30500000
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71743000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	84687000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	207256000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	218708000
CY2024Q3	us-gaap	Purchase Obligation PurchaseObligation	42100000
CY2024Q3	us-gaap	Recorded Unconditional Purchase Obligation Due In Next Rolling Twelve Months RecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths	30500000
CY2024Q3	us-gaap	Recorded Unconditional Purchase Obligation Due In Rolling Year Five RecordedUnconditionalPurchaseObligationDueInRollingYearFive	11600000
CY2024Q3	flgt	Potential Liability PotentialLiability	1000000
CY2024Q3	flgt	Estimated And Recorded Liability EstimatedAndRecordedLiability	6900000
	flgt	Operating Leases Term Of Expiration OperatingLeasesTermOfExpiration	2034-03
	flgt	Finance Leases Term Of Expiration FinanceLeasesTermOfExpiration	2026-12
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5970000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10838000
CY2024Q3	us-gaap	Recorded Unconditional Purchase Obligation Due In Rolling Year Five RecordedUnconditionalPurchaseObligationDueInRollingYearFive	11600000
CY2024Q3	flgt	Potential Liability PotentialLiability	1000000
CY2024Q3	flgt	Estimated And Recorded Liability EstimatedAndRecordedLiability	6900000
	flgt	Operating Leases Term Of Expiration OperatingLeasesTermOfExpiration	2034-03
	flgt	Finance Leases Term Of Expiration FinanceLeasesTermOfExpiration	2026-12
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5970000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10838000
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1481000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3957000
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4662000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7147000
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	909000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1316000
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	449000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	544000
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	767000
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1703000
	us-gaap	Operating Lease Cost OperatingLeaseCost	3744000
	us-gaap	Operating Lease Cost OperatingLeaseCost	5239000
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	134000
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	136000
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	407000
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	622000
CY2024Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	9000
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	909000
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	449000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	544000
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	448000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	760000
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	767000
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1703000
	us-gaap	Operating Lease Cost OperatingLeaseCost	3744000
	us-gaap	Operating Lease Cost OperatingLeaseCost	5239000
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	134000
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	136000
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	407000
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	622000
CY2024Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	9000
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	15000
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	32000
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	67000
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	360000
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	453000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	998000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1460000
CY2024Q3	us-gaap	Lease Cost LeaseCost	1270000
CY2023Q3	us-gaap	Lease Cost LeaseCost	2307000
	us-gaap	Lease Cost LeaseCost	5181000
	us-gaap	Lease Cost LeaseCost	7388000
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M17D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0528
CY2024Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y29D
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0353
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	15000
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	32000
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	67000
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	360000
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	453000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	998000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1460000
CY2024Q3	us-gaap	Lease Cost LeaseCost	1270000
CY2023Q3	us-gaap	Lease Cost LeaseCost	2307000
	us-gaap	Lease Cost LeaseCost	5181000
	us-gaap	Lease Cost LeaseCost	7388000
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M17D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0528
CY2024Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y29D
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0353
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	443000
CY2024Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	144000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1743000
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	420000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1148000
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	366000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1043000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	516000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	533000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1960000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7386000
CY2024Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	930000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1243000
CY2024Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	33000
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6143000
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	897000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	443000
CY2024Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	144000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1743000
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	420000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1148000
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	366000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1043000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	516000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	533000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1960000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7386000
CY2024Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	930000
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1243000
CY2024Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	33000
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6143000
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	897000
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10920000
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10902000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34073000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31490000
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3800000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6300000
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20300000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12000000
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.14
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	2.96
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.42
CY2024Q3	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	2900000
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	9800000
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10920000
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10902000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34073000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31490000
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3800000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6300000
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20300000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12000000
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.14
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	2.96
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.42
CY2024Q3	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	2900000
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	9800000
CY2023Q3	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	0
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	700000
CY2024Q3	us-gaap	Investment Tax Credit InvestmentTaxCredit	27100000
CY2024Q3	flgt	Income Tax Credit Under Transferability Provision Of Inflation Reduction Act IncomeTaxCreditUnderTransferabilityProvisionOfInflationReductionAct	24600000
CY2024Q3	flgt	Tax Credit Difference Amount Between Purchase Price And Face Value TaxCreditDifferenceAmountBetweenPurchasePriceAndFaceValue	2500000
	flgt	Cash Payment Included In Income Taxes Paid CashPaymentIncludedInIncomeTaxesPaid	24600000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	400000
	flgt	Income Tax Credit Carried Back Remainder Value IncomeTaxCreditCarriedBackRemainderValue	26700000
CY2024Q3	flgt	Increase In Prepaid Income Taxes In Other Current Assets IncreaseInPrepaidIncomeTaxesInOtherCurrentAssets	27100000
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14648000
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13107000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36820000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-39676000
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30416000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30013000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30095000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29789000
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30416000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30013000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30095000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29789000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.48
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.44
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.22
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.33
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.48
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.44
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.22
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.33
CY2023Q3	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	0
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	700000
CY2024Q3	us-gaap	Investment Tax Credit InvestmentTaxCredit	27100000
CY2024Q3	flgt	Income Tax Credit Under Transferability Provision Of Inflation Reduction Act IncomeTaxCreditUnderTransferabilityProvisionOfInflationReductionAct	24600000
CY2024Q3	flgt	Tax Credit Difference Amount Between Purchase Price And Face Value TaxCreditDifferenceAmountBetweenPurchasePriceAndFaceValue	2500000
	flgt	Cash Payment Included In Income Taxes Paid CashPaymentIncludedInIncomeTaxesPaid	24600000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	400000
	flgt	Income Tax Credit Carried Back Remainder Value IncomeTaxCreditCarriedBackRemainderValue	26700000
CY2024Q3	flgt	Increase In Prepaid Income Taxes In Other Current Assets IncreaseInPrepaidIncomeTaxesInOtherCurrentAssets	27100000
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14648000
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13107000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-36820000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-39676000
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30416000
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30013000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30095000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29789000
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30416000
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30013000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30095000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29789000
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.48
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.44
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.22
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.33
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.48
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.44
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.22
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.33
CY2024Q3	us-gaap	Goodwill Goodwill	22055000
CY2023Q4	us-gaap	Goodwill Goodwill	22055000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	137115000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	143053000
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6000000
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5900000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1996000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7985000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7678000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7216000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7181000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6924000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	33545000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	72525000
CY2024Q3	us-gaap	Goodwill Goodwill	22055000
CY2023Q4	us-gaap	Goodwill Goodwill	22055000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	137115000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	143053000
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6000000
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5900000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1996000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7985000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7678000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6924000
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	72525000
CY2022Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	250000000
CY2024Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	10000
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	200000
CY2024Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	200000
CY2023Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	80000
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	80000
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2200000
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2200000
CY2024Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	150500000
CY2024Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1200000
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3100000
CY2023Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	700000
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2500000
CY2022Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	250000000
CY2024Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	10000
CY2024Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	200000
CY2023Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	80000
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	80000
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2200000
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2200000
CY2024Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	150500000
CY2024Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1200000
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3100000
CY2023Q3	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	700000
	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2500000

Files In Submission

Name	View Source	Status
0000950170-24-123684-index-headers.html	Edgar Link	pending
0000950170-24-123684-index.html	Edgar Link	pending
0000950170-24-123684.txt	Edgar Link	pending
0000950170-24-123684-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
flgt-20240930.htm	Edgar Link	pending
flgt-20240930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
flgt-ex31_1.htm	Edgar Link	pending
flgt-ex31_2.htm	Edgar Link	pending
flgt-ex32_1.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
flgt-20240930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FLGT
Fulgent Genetics, Inc. Stock $flgt

2024 Q4 Form 10-Q Financial Statement

#000095017024123684 Filed on November 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FLGT Fulgent Genetics, Inc. Stock $flgt

2024 Q4 Form 10-Q Financial Statement

#000095017024123684 Filed on November 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FLGT
Fulgent Genetics, Inc. Stock $flgt